SUBSCRIBERS
Big pharma turns to artificial intelligence to speed up drug discovery process
Published Sun, Jul 2, 2017 · 09:50 PM
London
THE world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with Glaxo-SmithKline unveiling a new US$43 million deal in the field on Sunday.
Other pharmaceutical giants including Merck & Co, Johnson & Johnson and Sanofi are also exploring the potential of artificial intelligence (AI) to help streamline the drug discovery process.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
US sets up board to advise on safe, secure use of AI
Meta’s results are best viewed through rose-tinted AI glasses
'Harvesting data': Latin American AI startups transform farming
After long peace, Big Tech faces US antitrust reckoning
Tech’s cash crunch sees creditors turn ‘violent’ with one another
Tech millionaires chase billionaire tax shields with ‘swap fund’